Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cutting Edge Information
New report shows that expiring patents may cost pharmaceutical industry $80 billion
June 26th, 2004
According to a new report on the economic impact of generic drugs, more than $80 billion worth of blockbuster drugs faces patent expiration by 2008. These drugs risk losing 80% or greater market share when generic copies hit the market. The report, called "Combating Generics: Pharmaceutical Brand Defense," says that pharmaceutical industry brand managers can retain market share with advanced strategic planning and lifecycle management. The report examines a variety of product- and legal-based strategies available to product management teams for retaining market share even as generic competition reaches market. Each strategy, including "flanking"...
Source: Law & Health Weekly (2004-06-26)
|
